Items where contributor is "Antillon, Marina"

Article

Burrows, H. and Antillón, M. and Gauld, J. S. and Kim, J. H. and Mogasale, V. and Ryckman, T. and Andrews, J. R. and Lo, N. C. and Pitzer, V. E.. (2023) Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness. Vaccine, 41 (4). pp. 965-975.

Phillips, M. T. and Antillon, M. and Bilcke, J. and Bar-Zeev, N. and Limani, F. and Debellut, F. and Pecenka, C. and Neuzil, K. M. and Gordon, M. A. and Thindwa, D. and Paltiel, A. D. and Yaesoubi, R. and Pitzer, V. E.. (2023) Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study. BMC Infect Dis, 23. p. 143.

Antillon, M. and Huang, C. I. and Sutherland, S. A. and Crump, R. E. and Bessell, P. R. and Shaw, A. P. M. and Tirados, I. and Picado, A. and Biéler, S. and Brown, P. E. and Solano, P. and Mbainda, S. and Darnas, J. and Wang-Steverding, X. and Crowley, E. H. and Peka, M. and Tediosi, F. and Rock, K. S.. (2023) Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad. PLoS Negl Trop Dis, 17 (7). e0011396.

Antillón, M. and Li, X. and Willem, L. and Bilcke, J. and Resceu investigators, and Jit, M. and Beutels, P.. (2023) The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: a semi-parametric, meta-regression approach. PLoS Med, 20 (7). e1004250.

Antillón, M. and Huang, C. I. and Crump, R. E. and Brown, P. E. and Snijders, R. and Mwamba Miaka, E. and Keeling, M. J. and Rock, K. S. and Tediosi, F.. (2022) Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo. Nat Commun, 13. p. 1051.

Birger, R. and Antillón, M. and Bilcke, J. and Dolecek, C. and Dougan, G. and Pollard, A. J. and Neuzil, K. M. and Frost, I. and Laxminarayan, R. and Pitzer, V. E.. (2022) Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study. The Lancet infectious diseases, 22 (5). pp. 679-691.

Rock, K. S. and Huang, C. I. and Crump, R. E. and Bessell, P. R. and Brown, P. E. and Tirados, I. and Solano, P. and Antillón, M. and Picado, A. and Mbainda, S. and Darnas, J. and Crowley, E. H. and Torr, S. J. and Peka, M.. (2022) Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad. Infect Dis Poverty, 11. p. 11.

Sant Fruchtman, C. and Fischer, F. B. and Monzón Llamas, L. and Tavakkoli, M. and Cobos Muñoz, D. and Antillon, M.. (2022) Did COVID-19 policies have the same effect on covid-19 incidence among women and men? Evidence from Spain and Switzerland. International journal of public health, 67. p. 1604994.

Tavakkoli, M. and Karim, A. and Fischer, F. B. and Monzon Llamas, L. and Raoofi, A. and Zafar, S. and Sant Fruchtman, C. and de Savigny, D. and Takian, A. and Antillon, M. and Cobos Muñoz, D.. (2022) From public health policy to impact for COVID-19: a multi-country case study in Switzerland, Spain, Iran and Pakistan. International journal of public health, 67. p. 1604969.

Antillón, M. and Huang, C. I. and Rock, K. S. and Tediosi, F.. (2021) Economic evaluation of disease elimination: an extension to the net-benefit framework and application to human African trypanosomiasis. Proc Natl Acad Sci U S A, 118 (50). e2026797118.

Davis, C. N. and Rock, K. S. and Antillón, M. and Miaka, E. M. and Keeling, M. J.. (2021) Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo. BMC Med, 19. p. 86.

Li, Xiao and Willem, Lander and Antillon, Marina and Bilcke, Joke and Jit, Mark and Beutels, Philippe. (2020) Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries. BMC medicine, 18. p. 82.

Modelling Consortium Discussion Group on Gambiense Human African, N. T. D.. (2020) Insights from quantitative and mathematical modelling on the proposed 2030 goal for gambiense human African trypanosomiasis. Gates open research, 3. p. 1553.

Baral, Ranju and Li, Xiao and Willem, Lander and Antillon, Marina and Vilajeliu, Alba and Jit, Mark and Beutels, Philippe and Pecenka, Clint. (2020) The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: estimates from two models. Vaccine, 38 (33). pp. 5139-5147.

Leuba, S. I. and Yaesoubi, R. and Antillón, M. and Cohen, T. and Zimmer, C.. (2020) Tracking and predicting U.S. influenza activity with a real-time surveillance network. PLoS Comput Biol, 16 (11). e1008180.